Navigation Links
Health Robotics' CytoCare(TM) Global Expansion Continues With Grifols International in Latin America
Date:10/5/2009

BOZEN, Italy, October 5 /PRNewswire/ -- Health Robotics today announced that it has signed an exclusive five-year strategic partnership with Grifols International S.A. for its revolutionary CytoCare Robot. The agreement enables Grifols to add CytoCare to its prior i.v.STATION(TM) contract with Health Robotics, and achieve its objective to safely, accurately and cost-effectively automate the preparation of Oncology I.V. Admixtures in Mexico, Chile, Brazil, Argentina, Uruguay, Paraguay, Bolivia, Peru, Venezuela, Colombia, Ecuador, Panama, Costa Rica, Belize, Nicaragua, El Salvador, Honduras, Guatemala, Surinam, French Guyana, and Guyana. In addition, the contract between the companies also adds Mexico to Grifols' i.v.STATION distribution and support rights after Health Robotics recently accomplished the termination of its last Devon Robotics contract.

While other companies have for many years made promises of robotic IV automation products, and even showcased marketing demonstrations of competing solutions that were supposed to exist as far back as twenty years ago[1], the fact remains that CytoCare is the only available solution that currently exists anywhere in the world to automatically compound and prepare ready-to-administer hazardous IV Admixtures for Oncology and other drug classes, and that has been proven to work in a "live" hospital pharmacy environment, instead of just marketing hype, sales brochures, and "staged" demonstrations at pharmaceutical trade symposiums such as ASHP and EAHP.

"We are very excited to have been chosen by Health Robotics as their exclusive CytoCare partner in Latin America, and to add one of the largest Latin American markets [Mexico] to our i.v.STATION distribution rights. CytoCare, the world's first and only robotic system designed for the safe and sterile preparation of patient-specific hazardous IV Admixtures, represents an ideal complement to our other market-leading Pharmacy Automati
'/>"/>

SOURCE Health Robotics SRL
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. IncentOne Introduces Next Generation of Healthy Choice Award(TM) Incentive Solution to Drive Consumer and Provider Engagement
2. BioCryst to Present at JMP Securities Healthcare Conference
3. Alexza Pharmaceuticals to Present at the Fourth Annual JMP Securities Healthcare Focus Conference
4. Public Tells Health Care Workers: Get Your H1N1 Flu Vaccine!
5. Mobile Dog Heart Health Tour Stopping in Central Park to Provide Free Heart Examinations
6. Health Strategies Group Introduces Oncology Performance Edge
7. Echo Therapeutics to Present at 4th Annual JMP Securities Healthcare Conference
8. NeurogesX to Present at JMP Securities Healthcare Focus Conference
9. Baxa Addresses Health-System Capital Shortage With New Programs for IntelliFlowRx(TM) and IntelliFill i.v.(R)
10. TMS Health Continues to Expand - Adding Over 60 New Jobs at Boca Raton Headquarters
11. ActiViews Raised $5M Dollars, in a Round led by 7 Health

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)...ecember 2 Cardio Vascula...per of advanced,cardiovascular surgery technology,...tors approved a one-for-three forward stock split,...o Vascular Medical Device shareholders. , ...ated date the stock,split will be payable and the ...
(Date:12/2/2009)...2 Roche (SIX: RO, ROG; O...s Food & Drug Administration (FDA) approved an...acid test, to screen source plasma in pools compri...lled the cobas® TaqScreen MPX Test for use on...tro test for the simultaneous, direct detection of...
(Date:12/2/2009)...., Dec. 2 Novartis announced today...tion on Tasigna® (nilotinib) 200 mg capsules ... the strength of the company,s hematology portfoli...w data, at the 51st American Society of Hematology...e company,s current therapies and investigational ...
Breaking Medicine Technology:Cardio Vascular Medical Device Announces Forward Stock Split 2FDA Approves Use of Roche Test to Screen Source Plasma for HIV, Hepatitis B Virus and Hepatitis C Virus 2FDA Approves Use of Roche Test to Screen Source Plasma for HIV, Hepatitis B Virus and Hepatitis C Virus 3Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 2Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 3Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 4Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 5Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 6Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 7Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 8Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 9Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 10Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 11Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 12Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 13Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 14Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 15Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 16Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 17Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 18Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 19Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 20Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 21Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 22Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 23Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 24Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 25American Medical Informatics Association 28AMIA 29 Submits Comments to Hit Policy Committee About Meaningful Use and Electronic Health Record Certifi 13045 1American Medical Informatics Association 28AMIA 29 Submits Comments to Hit Policy Committee About Meaningful Use and Electronic Health Record Certifi 13045 2National Coalition of Mental Health Consumer Survivor Organizations Hires Director of Government Relations 51792 1National Coalition of Mental Health Consumer Survivor Organizations Hires Director of Government Relations 51792 2Proposed Water Trust Fund Bill Would Provide Solid Foundation for Improvement 51788 1Proposed Water Trust Fund Bill Would Provide Solid Foundation for Improvement 51788 2
...Time, Newsweek,and U.S. World and News are all buz...earchers have found compelling evidence that these...ve and immune health, but Eastern,Europeans have b...und in,fermented foods such as yogurt, for centuri...obiotic benefits, Russian scientists have been awa...
...diac Toxicity With Equivalent Co... Cell Therapeutics, Inc.,(CTI) (Nasdaq and MTAX: ...ts phase II/III randomized study comparing CPOP-R ...with aggressive non-Hodgkin,s lymphoma,(NHL) showe...s severe,(grade 3/4) toxicities including severe i...
Other Medicine Technology:Are Muramyl Peptides the Magic Bullet in Probiotics? 2Are Muramyl Peptides the Magic Bullet in Probiotics? 3Pixantrone Versus Doxorubicin in CHOP-R Therapy for First-line Treatment of Aggressive Non-Hodgkin's Lymphoma Preliminary Results Presented at American Society of Hematology (ASH) Annual Meeting 2Pixantrone Versus Doxorubicin in CHOP-R Therapy for First-line Treatment of Aggressive Non-Hodgkin's Lymphoma Preliminary Results Presented at American Society of Hematology (ASH) Annual Meeting 3Pixantrone Versus Doxorubicin in CHOP-R Therapy for First-line Treatment of Aggressive Non-Hodgkin's Lymphoma Preliminary Results Presented at American Society of Hematology (ASH) Annual Meeting 4Pixantrone Versus Doxorubicin in CHOP-R Therapy for First-line Treatment of Aggressive Non-Hodgkin's Lymphoma Preliminary Results Presented at American Society of Hematology (ASH) Annual Meeting 5
(Date:12/2/2009)...mation detailing plastic surgery procedures is now...cal candidates can view procedures and print out i... (PRWEB) December 2, 2009 --... retailer, has always been dedicated to providing ... procedures, providing liposuction garments, breas...
(Date:12/2/2009)...hoice.com Enables Personal Health Record Devices w...Washington, PA (PRWEB) December 2, 2009 -- Perhaps...ead their own medical records. With the advent of ...rsonal medical records is easier than ever. MyEMRC...technology company has added services that will po...
(Date:12/2/2009)...winning author James A. Feinstein, MD, has just re...t: Lessons from Patients on Becoming a Doctor, tha...edical school--the grueling clinical year. , ...mber 2, 2009 -- Most people will, at some point or... hospital gown or staring at someone else dressed ...
(Date:12/2/2009)...g medical device software engineering consulting f...certification. A relatively few medical device sof...chieved ISO 13485 certification. Many medical devi...to other ISO standards as well. However, it is som...ng consulting firm to achieve the rigorous quality...
(Date:12/2/2009)...PRNewswire-FirstCall/ -- Gen-Probe Incorporated (N...er Jaffray Health Care Conference today at 2:30 p....be webcast live and may be accessed through a link...t www.gen-probe.com . The webcast will be availab...en-Probe ,, Gen-Probe Incorporated is a globa...
Breaking Medicine News(10 mins):Health News:Online Compression Garments Retailer Introduces 3D Animation of Surgical Procedures 2Health News:Personal Health Records On-Demand, In Your Pocket 2Health News:Beneath the Short White Coat: A Medical Student Reveals All 2Health News:Medical Device Software Engineering Consulting firm Full Spectrum Software Earns ISO 13485 Certification 2Health News:Gen-Probe to Webcast Presentation at the 21st Annual Piper Jaffray Health Care Conference Today 2
...dren how to keep hands clean, MORRIS PLAINS, N.J....d in his/her nose or mouth. Considering that,some ...on surfaces like,cafeteria tables, doorknobs, and ...ase Control and Prevention (CDC),keeping hands cle...
...,Corporation, Inc. (OTC Bulletin Board: POCI), (th...an unaudited basis for the first quarter of,fiscal...r Operating Results Revenues -- Total revenues fo...cond highest quarterly revenue in six,years. The i...
...One Million Dollars to Help People ...LLS, Calif., Nov. 20 Fitness website,MillionDolla...r in its,Million Dollar Body Game(TM), an ongoing ...ust won $10,000 for losing 50 pounds,through a reg...
... surgeries, study finds , , TUESDAY, Nov. ...e suffered facial wounds are now undergoing succe...in the field -- cutting their risk for long-term ...air face wounds in Iraq, explained co-researcher D...
...,Michigan,s 1993 tort reforms are working is that ...insurer is cutting its premiums by 12 to 25,percen...Medical Society,(MSMS) announced today at a news c...ns Assurance,Corporation, a medical liability insu...
...al,Health, Inc., one of the companies of EMPLOYERS...n awarded Case Management Accreditation from URAC,...organization that,establishes quality standards fo... management interventions. (Logo: http://www.new...
Other Medicine News:Health News:Proper Hand Hygiene Is Key to Avoiding Illness During Cold and Flu Season 2Health News:Precision Optics Corporation Announces First Quarter Results and Receipt of Significant New Order 2Health News:Precision Optics Corporation Announces First Quarter Results and Receipt of Significant New Order 3Health News:Precision Optics Corporation Announces First Quarter Results and Receipt of Significant New Order 4Health News:Precision Optics Corporation Announces First Quarter Results and Receipt of Significant New Order 5Health News:Precision Optics Corporation Announces First Quarter Results and Receipt of Significant New Order 6Health News:Shreveport, LA Mother Wins $10,000 for Losing 50 Pounds 2Health News:Shreveport, LA Mother Wins $10,000 for Losing 50 Pounds 3Health News:In-the-Field Facial Surgery Helps Injured Troops in Iraq 2Health News:In-the-Field Facial Surgery Helps Injured Troops in Iraq 3Health News:Michigan State Medical Society Says Rate Drop Shows Tort Reform is Working 2Health News:Michigan State Medical Society Says Rate Drop Shows Tort Reform is Working 3Health News:Employers Occupational Health, Inc. Receives URAC Case Management Accreditation 2
2005 Edition of Geriatrics At Your Fingertips (PDA Version)
...Consultant, PDA Edition is designed for all physic...tic imaging studies. It provides speedy access via...t will help to determine whether imaging examinati...udies will generate the most information. The cont...
KR-8800 Auto Kerato-Refractometer
Medical Student's PDA Reference
Medicine Products: